Dr Reddy's Laboratories Ltd
BSE:500124

Watchlist Manager
Dr Reddy's Laboratories Ltd Logo
Dr Reddy's Laboratories Ltd
BSE:500124
Watchlist
Price: 1 214.8 INR 0.53% Market Closed
Market Cap: ₹202.3B

Operating Margin

18.2%
Current
Declining
by 3.4%
vs 3-y average of 21.6%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
18.2%
=
Operating Income
₹63.2B
/
Revenue
₹346.8B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
18.2%
=
Operating Income
₹63.2B
/
Revenue
₹346.8B

Peer Comparison

Country Company Market Cap Operating
Margin
IN
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
1T INR
Loading...
ZA
Aspen Pharmacare Holdings Ltd
JSE:APN
486.8m ZAR
Loading...
US
Eli Lilly and Co
NYSE:LLY
978.7B USD
Loading...
US
Johnson & Johnson
NYSE:JNJ
547.3B USD
Loading...
CH
Roche Holding AG
SIX:ROG
277.3B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
210B GBP
Loading...
CH
Novartis AG
SIX:NOVN
220.8B CHF
Loading...
US
Merck & Co Inc
NYSE:MRK
273B USD
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.6T DKK
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
150.2B USD
Loading...

Market Distribution

Higher than 80% of companies in India
Percentile
80th
Based on 5 437 companies
80th percentile
18.2%
Low
-153 833.3% — 2.7%
Typical Range
2.7% — 13.2%
High
13.2% — 9 977%
Distribution Statistics
India
Min -153 833.3%
30th Percentile 2.7%
Median 7.3%
70th Percentile 13.2%
Max 9 977%

Dr Reddy's Laboratories Ltd
Glance View

In the bustling world of pharmaceuticals, Dr. Reddy's Laboratories Ltd. stands as a testament to innovation and resilience. Founded in 1984 by Dr. K. Anji Reddy, the company embarked on a journey to provide affordable and accessible medicine. Dr. Reddy's merged scientific rigor with a clear vision to eliminate health disparities worldwide. From creating complex generics and active pharmaceutical ingredients (APIs) to providing differentiated formulations, the company has built a strong foundation in both developed markets, like the United States and Europe, as well as in emerging markets such as India, Russia, and the CIS countries. This global footprint ensures that while many pharmaceutical companies are battling regulatory challenges and pricing pressures, Dr. Reddy's stays agile and competitive. The company's revenue streams primarily derive from its diverse portfolio of generic drugs, APIs, branded formulations, biologics, and proprietary products. Each sector is a strategic puzzle piece that enhances its market presence and ensures supply chain efficiency. Dr. Reddy's invests heavily in research and development to bolster its pipeline of future medications, aiming to address unmet medical needs and introduce value-added products. By leveraging strategic alliances and forging partnerships in development and distribution, the company adeptly navigates the complex landscape of the pharmaceutical industry, ensuring sustainable growth and reaffirming its commitment to affordable healthcare globally.

DRREDDY Intrinsic Value
1 067.8 INR
Overvaluation 12%
Intrinsic Value
Price
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
18.2%
=
Operating Income
₹63.2B
/
Revenue
₹346.8B
What is Dr Reddy's Laboratories Ltd's current Operating Margin?

The current Operating Margin for Dr Reddy's Laboratories Ltd is 18.2%, which is below its 3-year median of 21.6%.

How has Operating Margin changed over time?

Over the last 3 years, Dr Reddy's Laboratories Ltd’s Operating Margin has decreased from 20.1% to 18.2%. During this period, it reached a low of 18.2% on Jan 1, 2026 and a high of 23.7% on Jun 30, 2023.

Back to Top